WallStreetZenWallStreetZen

NASDAQ: DCOY
Decoy Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their DCOY stock forecasts and price targets.

Forecast return on equity

Is DCOY forecast to generate an efficient return?

Company
-128.06%
Industry
-10.97%
Market
139.15%
DCOY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DCOY forecast to generate an efficient return on assets?

Company
-61.47%
Industry
-13.21%
DCOY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DCOY earnings per share forecast

What is DCOY's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$9.14-172.76%
Avg 2 year Forecast
-$8.45-167.24%

DCOY revenue forecast

What is DCOY's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$12.1M+5,221.38%
DCOY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DCOY revenue growth forecast

How is DCOY forecast to perform vs Biotechnology companies and vs the US market?

Company
5,221.38%
Industry
11.4%
Market
23.25%
DCOY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DCOY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DCOY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DCOY$1.17N/AN/A
VRAX$1.45N/AN/A
CRIS$0.41$43.00+10,465.11%Buy
SLXN$0.15N/AN/A
HLSQ$0.22N/AN/A
View Top Biotech Stocks

Decoy Therapeutics Stock Forecast FAQ

What is DCOY's earnings growth forecast for 2026-2027?

(NASDAQ: DCOY) Decoy Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,293.11%.

Decoy Therapeutics's earnings in 2026 is -$14,449,550.On average, 3 Wall Street analysts forecast DCOY's earnings for 2026 to be -$5,987,867, with the lowest DCOY earnings forecast at -$5,753,048, and the highest DCOY earnings forecast at -$6,163,980.

In 2027, DCOY is forecast to generate -$5,533,430 in earnings, with the lowest earnings forecast at -$5,316,433 and the highest earnings forecast at -$5,696,178.

If you're new to stock investing, here's how to buy Decoy Therapeutics stock.

What is DCOY's revenue growth forecast for 2026-2026?

(NASDAQ: DCOY) Decoy Therapeutics's forecast annual revenue growth rate of 5,221.38% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 11.4%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.25%.

Decoy Therapeutics's revenue in 2026 is $227,629.

In 2026, DCOY is forecast to generate $7,936,256 in revenue, with the lowest revenue forecast at $7,625,043 and the highest revenue forecast at $8,169,502.

What is DCOY's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: DCOY) forecast ROA is -61.47%, which is lower than the forecast US Biotechnology industry average of -13.21%.

What is DCOY's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: DCOY) Decoy Therapeutics's current Earnings Per Share (EPS) is $12.56. On average, analysts forecast that DCOY's EPS will be -$9.14 for 2026, with the lowest EPS forecast at -$8.78, and the highest EPS forecast at -$9.41. In 2027, DCOY's EPS is forecast to hit -$8.45 (min: -$8.11, max: -$8.69).

What is DCOY's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: DCOY) forecast ROE is -128.06%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.